Pfizer (Australia) SODIUM BICARBONATE 8.4% (8.4g/100mL) injection BP vial

产品概览

About Pfizer (Australia) SODIUM BICARBONATE 8.4% (8.4g/100mL) injection BP vial

Pfizer (Australia) SODIUM BICARBONATE 8.4% (8.4g/100mL) injection BP vial is a medication containing the active ingredient Sodium Bicarbonate. Sodium bicarbonate (IUPAC name: sodium hydrogen carbonate), commonly known as baking soda or bicarbonate of soda (or simply "bicarb", especially in the UK), or saleratus, is a chemical compound with the formula NaHCO3. It is a salt composed of a sodium cation (Na+) and a bicarbonate anion (HCO3–).

Key Benefits & Uses

• Used for: INDICATIONS AND USAGE Elliotts B Solution is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Sodium Bicarbonate, the active ingredient in Pfizer (Australia) SODIUM BICARBONATE 8.4% (8.4g/100mL) injection BP vial, is the pharmacologically active substance of this product. INDICATIONS AND USAGE Elliotts B Solution is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatment of meningeal leukemia or lymphocytic lymphoma. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Pfizer (Australia) SODIUM BICARBONATE 8.4% (8.4g/100mL) injection BP vial. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Pfizer (Australia) SODIUM BICARBONATE 8.4% (8.4g/100mL) injection BP vial for extended periods without medical advice.